Chemotherapy in bone and joint tuberculosis

Citation
M. Serke et al., Chemotherapy in bone and joint tuberculosis, ORTHOPADE, 28(4), 1999, pp. 375-380
Citations number
27
Categorie Soggetti
Ortopedics, Rehabilitation & Sport Medicine
Journal title
ORTHOPADE
ISSN journal
00854530 → ACNP
Volume
28
Issue
4
Year of publication
1999
Pages
375 - 380
Database
ISI
SICI code
0085-4530(199904)28:4<375:CIBAJT>2.0.ZU;2-D
Abstract
Bone and joint tuberculosis, as all other types of tuberculosis is generall y treated with antituberculotic combination chemotherapy. This has to be co ntinued for a minimum of six months, or nine months in case of extensive sp reading. A two- to three-month initial phase with four or five different dr ugs (H, R, Z, and additionally E and/or S) is followed by a four- to six-mo nth therapy with H and R alone, provided the pathogen is fully susceptible to a standard regimen. The main side effects are hepatotoxic or allergic re actions. A frequent contra-indication is existing, often toxicity-induced, liver damage. The main local complications requiring surgery are spinal ins tability or neurologic deficiencies.